Arcutis Biotherapeutics Statistics
NASDAQ: ARQTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
24.17+0.25 (+1.05%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Arcutis Biotherapeutics by the numbers
Arcutis Biotherapeutics has a market capitalization of $3.04 billion based on 125.69M shares outstanding. Its trailing P/E ratio is 109.9, and its forward P/E is 17.8. The stock trades 5.2% below its 50-day average and 3.9% below its 200-day average.
Average daily trading volume is 2.22M shares, or about $53.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ARQT valuation vs. peer median
| Metric | ARQT | Peer median | Difference |
|---|---|---|---|
| Market cap | $3.04B | $2.91B | +4% |
| Avg. volume | 2.22M | 1.58M | +40% |
Peer median across 8 companies: ELVN, DYN, RCUS, ZLAB, MRVI, PGEN, ACAD, MBX.
Valuation
- Market cap
- $3.04B
- P/E (TTM)
- 109.86
- Forward P/E
- 17.77
- Price / sales (latest FY)
- 8.08
- EPS (TTM)
- $0.22
- Shares outstanding
- 125.69M
Price and trading
- Previous close
- 23.92
- Open
- 23.74
- Day range
- 23.51 – 24.38
- 52-week range
- 19.30 – 31.77
- 52-week change
- +17.50%
- Beta
- —
- Volume
- 1.70M
- Average volume
- 2.22M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 27, 2026
Additional statistics
- Market Cap
- 3.04B
- Pe
- 109.86
- Forward Pe
- 17.77
- Eps
- 0.22
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 31.77
- Week52 Low
- 19.30
- Avg Volume
- 2.22M
- Shares Outstanding
- 125.69M
- Ma50
- 25.49
- Ma200
- 25.15
- Earnings Date
- Oct 27, 2026
- Pct From52w High
- -23.92%
- Pct From52w Low
- 25.27%